Zacks Investment Research upgraded shares of JMP Group (NYSE:JMP) from a hold rating to a strong-buy rating in a report released on Thursday. The firm currently has $6.25 price objective on the financial services provider’s stock.
According to Zacks, “JMP GROUP INC. is a full-service investment banking and asset management firm that provides investment banking, sales and trading, and equity research services to corporate and institutional clients and alternative asset management products to institutional and high-net-worth investors. JMP Group operates through two subsidiaries, JMP Securities and JMP Asset Management. The company focuses its resources on small and middle-market growth companies and the institutions that invest in them. They approach their work with the idea that expertise, intellectual capital and relationships can never be commoditized. “
Hot Financial Stocks To Invest In Right Now: Carbonite, Inc.(CARB)
Advisors' Opinion:- [By Joseph Griffin]
Analysts at Jefferies Financial Group initiated coverage on shares of Carbonite (NASDAQ:CARB) in a research report issued on Friday, MarketBeat Ratings reports. The firm set a “buy” rating and a $45.00 price target on the technology company’s stock. Jefferies Financial Group’s price objective points to a potential upside of 33.53% from the stock’s current price.
- [By Logan Wallace]
Get a free copy of the Zacks research report on Carbonite (CARB)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
- [By Joseph Griffin]
BidaskClub lowered shares of Carbonite (NASDAQ:CARB) from a strong-buy rating to a buy rating in a research report report published on Tuesday.
Several other equities research analysts also recently weighed in on the stock. Zacks Investment Research raised shares of Carbonite from a hold rating to a buy rating and set a $33.00 target price on the stock in a research note on Tuesday, March 20th. B. Riley upped their target price on shares of Carbonite from $30.00 to $37.00 and gave the stock a buy rating in a research note on Wednesday, February 14th. Lake Street Capital reaffirmed a buy rating and set a $27.00 target price (up from $25.00) on shares of Carbonite in a research note on Wednesday, February 14th. TheStreet downgraded shares of Carbonite from a c+ rating to a d rating in a research note on Tuesday, February 13th. Finally, JMP Securities raised shares of Carbonite to an outperform rating in a research note on Sunday, April 29th. Two investment analysts have rated the stock with a hold rating, seven have issued a buy rating and one has issued a strong buy rating to the stock. The company currently has an average rating of Buy and an average target price of $33.63.
- [By Logan Wallace]
Carbonite Inc (NASDAQ:CARB) shares reached a new 52-week high and low during mid-day trading on Friday . The company traded as low as $37.23 and last traded at $37.20, with a volume of 8859 shares changing hands. The stock had previously closed at $36.32.
Hot Financial Stocks To Invest In Right Now: Keysight Technologies Inc.(KEYS)
Advisors' Opinion:- [By Lisa Levin] Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares surged 144.96 percent to close at $265.61 on Thursday in reaction to an encouraging Phase 2 clinical trial update. The clinical-stage biopharmaceutical company said its liver-directed, thyroid hormone receptor called MGL-3196 showed a statistical significance in the primary endpoint of lowering liver fat at 12 weeks and also 36 weeks. Viking Therapeutics, Inc. (NASDAQ: VKTX) shares rose 101.01 percent to close at $9.99 on Thursday after falling 4.42 percent on Wednesday. Akers Biosciences, Inc. (NASDAQ: AKER) jumped 45.58 percent to close at $0.474. The developer of rapid health information technologies said Wednesday afternoon it was granted a 180-day extension from the Nasdaq Stock Market to meet the requirement of a minimum $1.00 per share closing bid price for 10 straight days. Kitov Pharma Ltd (NASDAQ: KTOV) gained 40.93 percent to close at $3.03 after the FDA approved Kitov's Consensi for the treatment of osteoarthritis pain and hypertension. China Customer Relations Centers, Inc. (NASDAQ: CCRC) rose 28.21 percent to close at $19.86. J.Jill, Inc. (NYSE: JILL) climbed 26.45 percent to close at $7.84 after the company posted upbeat quarterly earnings. Curis, Inc. (NASDAQ: CRIS) shares climbed 21.93 percent to close at $2.78 in reaction to an encouraging FDA update. The biotechnology company that focuses on therapies for the treatment of cancer said the FDA granted a Fast Track designation for fimepinostat (CUDC-907) in patients with relapsed or refractory. Boxlight Corporation (NASDAQ: BOXL) gained 21.23 percent to close at $7.48. Kirkland's, Inc. (NASDAQ: KIRK) rose 16.21 percent to close at $12.83 after reporting upbeat Q1 results. The Brink's Company (NYSE: BCO) jumped 16.2 percent to close at $79.25 as the company announced plans to acquire Dunbar Armored for $520 million in cash. Applied Optoelectronics, Inc. (NASDAQ: AAOI) rose 15.14 percent to c
- [By Max Byerly]
Barings LLC raised its position in Keysight (NYSE:KEYS) by 3.2% during the first quarter, HoldingsChannel.com reports. The firm owned 73,271 shares of the scientific and technical instruments company’s stock after buying an additional 2,300 shares during the quarter. Barings LLC’s holdings in Keysight were worth $3,839,000 at the end of the most recent quarter.
- [By Lisa Levin]
Thursday afternoon, the information technology shares surged 0.47 percent. Meanwhile, top gainers in the sector included Keysight Technologies, Inc. (NYSE: KEYS), up 12 percent, and QAD Inc. (NASDAQ: QADB) up 11 percent.
- [By Motley Fool Transcribers]
Keysight Technologies Inc (NYSE:KEYS)Q1 2019 Earnings Conference CallFeb. 21, 2019, 4:30 p.m. ET
Contents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks:Operator
Hot Financial Stocks To Invest In Right Now: Microsoft Corporation(MSFT)
Advisors' Opinion:- [By ]
Bill Gates, Microsoft (NASDAQ: MSFT) founder and internet godfather, penned an essay in 1996 that contained the now famous quote "content is king." Gates' thesis was that the internet would become a marketplace for content.
- [By Paul Ausick]
Microsoft Corp. (NASDAQ: MSFT) traded up 1.00% at $94.55. The stock’s 52-week range is $67.14 to $97.90. Volume was nearly 30% below the daily average of around 34.6 million. The company had no specific news. The company said today that sales of its Xbox One console are up 15% compared with 2017 sales for the same period.
- [By Ashraf Eassa]
On July 19, software giant Microsoft (NASDAQ:MSFT) is set to report earnings for the fourth and final quarter of its 2018 fiscal year. Last quarter, Microsoft delivered strong results. Revenue soared 16% to $26.8 billion, and diluted earnings per share popped 36%, reaching $0.95.
- [By Paul Ausick]
The second-best performer among the Dow index equities so far this year is Microsoft Corp. (NASDAQ: MSFT), which is up 33.7%. That is followed by Apple Inc. (NASDAQ: AAPL), up 33.4%, then Visa Inc. (NYSE: V), up 31.6%, and Cisco Systems Inc. (NASDAQ: CSCO), up 27.0%. Of the 30 Dow stocks, 19 have managed to post a gain to date in 2018.
- [By Max Byerly]
Miracle Mile Advisors LLC lifted its position in shares of Microsoft Co. (NASDAQ:MSFT) by 127.1% during the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 31,683 shares of the software giant’s stock after acquiring an additional 17,731 shares during the period. Miracle Mile Advisors LLC’s holdings in Microsoft were worth $2,892,000 at the end of the most recent reporting period.
No comments:
Post a Comment